» Articles » PMID: 36649710

The NLRP1 and CARD8 Inflammasomes Detect Reductive Stress

Overview
Journal Cell Rep
Publisher Cell Press
Date 2023 Jan 17
PMID 36649710
Authors
Affiliations
Soon will be listed here.
Abstract

The danger signals that activate the related nucleotide-binding domain leucine-rich repeat pyrin domain-containing 1 (NLRP1) and caspase activation and recruitment domain-containing 8 (CARD8) inflammasomes have not been fully established. We recently reported that the oxidized form of TRX1 binds to NLRP1 and represses inflammasome activation. These findings suggested that intracellular reductive stress, which would reduce oxidized TRX1 and thereby abrogate the NLRP1-TRX1 interaction, is an NLRP1 inflammasome-activating danger signal. However, no agents that induce reductive stress were known to test this premise. Here, we identify and characterize several radical-trapping antioxidants, including JSH-23, that induce reductive stress. We show that these compounds accelerate the proteasome-mediated degradation of the repressive N-terminal fragments of both NLRP1 and CARD8, releasing the inflammasome-forming C-terminal fragments from autoinhibition. Overall, this work validates chemical probes that induce reductive stress and establishes reductive stress as a danger signal sensed by both the NLRP1 and CARD8 inflammasomes.

Citing Articles

Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation.

Gorse L, Plessis L, Wearne S, Paradis M, Pinilla M, Chua R EMBO Mol Med. 2025; 17(3):535-562.

PMID: 39948420 PMC: 11903881. DOI: 10.1038/s44321-025-00197-4.


A mitochondrial redox switch licenses the onset of morphogenesis in animals.

Kahlon U, Ricca F, Pillai S, Olivetta M, Tharp K, Jao L bioRxiv. 2024; .

PMID: 39553983 PMC: 11565760. DOI: 10.1101/2024.10.28.620733.


Molecular mechanisms of emerging inflammasome complexes and their activation and signaling in inflammation and pyroptosis.

Pandey A, Li Z, Gautam M, Ghosh A, Man S Immunol Rev. 2024; 329(1):e13406.

PMID: 39351983 PMC: 11742652. DOI: 10.1111/imr.13406.


Inflammasome activity regulation by PUFA metabolites.

Atalay Ekiner S, Gegotek A, Skrzydlewska E Front Immunol. 2024; 15:1452749.

PMID: 39290706 PMC: 11405227. DOI: 10.3389/fimmu.2024.1452749.


Activation of the NLRP1B inflammasome by caspase-8.

Meade J, Stuart S, Neiman-Zenevich J, Krustev C, Girardin S, Mogridge J Commun Biol. 2024; 7(1):1164.

PMID: 39289441 PMC: 11408587. DOI: 10.1038/s42003-024-06882-3.


References
1.
Okondo M, Rao S, Taabazuing C, Chui A, Poplawski S, Johnson D . Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome. Cell Chem Biol. 2018; 25(3):262-267.e5. PMC: 5856610. DOI: 10.1016/j.chembiol.2017.12.013. View

2.
DOsualdo A, Weichenberger C, Wagner R, Godzik A, Wooley J, Reed J . CARD8 and NLRP1 undergo autoproteolytic processing through a ZU5-like domain. PLoS One. 2011; 6(11):e27396. PMC: 3210808. DOI: 10.1371/journal.pone.0027396. View

3.
Tu B, Weissman J . Oxidative protein folding in eukaryotes: mechanisms and consequences. J Cell Biol. 2004; 164(3):341-6. PMC: 2172237. DOI: 10.1083/jcb.200311055. View

4.
Linder A, Bauernfried S, Cheng Y, Albanese M, Jung C, Keppler O . CARD8 inflammasome activation triggers pyroptosis in human T cells. EMBO J. 2020; 39(19):e105071. PMC: 7527815. DOI: 10.15252/embj.2020105071. View

5.
Liu Q, Yin X, Languino L, Altieri D . Evaluation of drug combination effect using a Bliss independence dose-response surface model. Stat Biopharm Res. 2019; 10(2):112-122. PMC: 6415926. DOI: 10.1080/19466315.2018.1437071. View